Nevro Corp. (NYSE:NVRO) said yesterday that it named former Thoratec CEO Keith Grossman to replace president & CEO Rami Elghandour after striking a deal with one of its investors, Broadfin Capital. Grossman re-joined Thoratec after taking over at Conceptus in December 2011 and leading it to a $1.1 billion sale to Bayer in June 2013 (he’d […]
11 innovative medical devices you need to know from 2018
Call it digital health or mHealth or simply what it is — innovation. Last year we saw a lot of innovative wireless devices for diagnostics and treatment as research and development flourished. Many researchers have taken up the challenge of developing devices that are portable, small and convenient with ease-of-use that could revolutionize point-of-care diagnostics […]
ElectroCore wins 5-year GammaCore federal supply deal
ElectroCore said yesterday it won a five-year Federal Supply Schedule Medical Equipment and Supply Contract with the U.S. Federal Government. Through the newly awarded contract, the Basking Ridge, N.J.-based company will supply its GammaCore non-invasive vagus nerve stimulation therapy to the Dept. of Veteran’s Affairs, the Dept. of Defense, the Bureau of Prisons, Indian Health Services […]
ElectroCore wins cluster headache FDA 510(k) indication for GammaCore
ElectroCore said today that it won expanded FDA 510(k) clearance for its GammaCore non-invasive vagus nerve stimulation therapy, now cleared for adjunctive use for the preventive treatment of cluster headaches in adult patients. The Basking Ridge, N.J.-based company’s GammaCore device is a non-invasive, hand-held vagus nerve stimulation device designed for the reduction of pain. The system […]
ElectroCore inks nVNS neuroinflammatory response research deal with MGH
ElectroCore said yesterday it inked a collaborative research deal with Massachusetts General Hospital exploring the use of ElectroCore’s non-invasive vagus nerve stimulation tech in targeted treatments for neuroinflammation. The Basking Ridge, N.J.-based company said that investigators will examine the effects the nVNS system has on neuroinflammatory mechanisms associated with conditions in the central nervous system including […]
Electrocore registers $75m IPO
Electrocore yesterday registered for an initial public offering worth nearly $75 million, detailing plans to expand its GammaCore device beyond the two headache treatments it’s already cleared for in the U.S. The Basking Ridge, N.J.-based company said in a regulatory filing that it plans to use the $74.8 million IPO’s net proceeds to expand its sales […]
Electrocore wins FDA nod for GammaCore acute migraine treatment indication
Electrocore said today it won FDA 510(k) clearance for its GammaCore device, expanding indications to include the acute treatment of pain associated with migraines in adult patients. The Basking Ridge, N.J.-based company’s GammaCore device is a non-invasive, hand-held vagus nerve stimulation device designed for the reduction of pain. The system is intended to be applied to […]
Electrocore closes $70m Series B
Electrocore said today it closed a $70 million Series B round of financing to support the commercial launch of its gammaCore therapy system into the primary headache market. The round was led by investment group Core Ventures II and joined by Merck’s Global Health Innovation Fund, Knoll Capital Management affiliate Gakasa, American Investment Holdings and […]
ElectroCore raises $36m, looks to raise $29m more
ElectroCore has raised $36 million in a new round of equity and options financing, according to an SEC filing posted this week. The Basking Ridge, N.J.-based company is seeking an additional $29 million in the round to bring the total to $65 million. Funds raised so far have come from 31 unnamed investors, with the […]
ElectroCore launches gammaCore handheld VNS in US
Neuroscience tech developer ElectroCore said today it launched its gammaCore non-invasive vagus nerve stimulator, designed for the acute treatment of pain associated with episodic cluster headaches in adult patients, in the US. The Basking Ridge, N.J.-based company touted the device as the 1st non-invasive, hand-held vagus nerve stimulation device for the reduction of pain. The system […]
ElectroCore touts gammaCore cluster headache trial data
Neuroscience tech developer ElectroCore today released data from the ACT clinical trials exploring the use of its gammaCore non-invasive vagus nerve stimulator for treating patients with episodic cluster headaches. Results from the study were presented at the 59th Annual Scientific Meeting of the American Headache Society, the company said. The 250-patient studies evaluated the safety and efficacy of the […]
MassDevice Network
@MassDevice
LinkedIn
YouTube